Acute Myelogenous Leukemia (AML)

A Phase 1B/2A Trial of NADUNOLIMAB in Combination With Azacitidine (With/Without Venetoclax) in Patients With Myelodysplastic Syndrome (MDS) and Acute Myelogenous Leukemia (AML)

Stem Cell Transplantation With NiCord® (Omidubicel) vs Standard UCB in Patients With Leukemia, Lymphoma, and MDS

HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy

Cord Blood Transplant in Adults With Blood Cancers

HLA-Mismatched Unrelated Donor Bone Marrow Transplantation With Post-Transplantation Cyclophosphamide

CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant

Maintenance Low Dose 5'-Azacitidine Post T Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Myelodysplastic Syndrome and Acute Myelogenous Leukemia With High Risk for Post-Transplant Relapse

Safety, Tolerability, and Pharmacokinetic/Pharmacodynamic Study of KW-2449 in Acute Myelogenous Leukemia (AML) (Protocol Number: 2449-US-002)

Relapse Prophylaxis With N-803 for AML and MDS Pts Following Allo HSCT

A Study of the Effect of Blood Stem Cell Transplant After Chemotherapy Alone in Patients With Fanconi Anemia

MAX-40279 in Subjects With Acute Myelogenous Leukemia (AML)

Eltrombopag in Elderly Acute Myelogenous Leukemia (AML)

Pilot Study Evaluating Safety & Efficacy of DCBT: NiCord® & UNM CBU to Patients With Hematological Malignancies

Unrelated Umbilical Cord Blood (UBC)Transplantation

Vidaza and Valproic Acid Post Allogeneic Transplant for High Risk AML and MDS

Expanded Access for CC-486

IL-15 Super Agonist ALT-803 to Treat Relapse Of Hematologic Malignancy After Allogeneic SCT

Non-interventional, Long-term Follow-up of Subjects Who Completed ApoGraft-01 Study

Safety, Pharmacokinetics, and Pharmacodynamics of Oral Azacitidine in Subjects With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia and Acute Myelogenous Leukemia

Omacetaxine for Consolidation and Maintenance